Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Regulus, Rutgers, Monsanto, and More

Premium

Title: Oligomeric Compounds and Compositions for Use in Modulation of Small, Non-coding RNAs

Patent Number: 8,697,663

Filed: Dec. 30, 2008

Lead Inventor: Frank Bennett, Regulus Therapeutics


Title: Cyclodextrin-modified Polyamines for Delivery of Therapeutics Molecules

Patent Number: 8,697,667

Filed: Oct. 11, 2011

Lead Inventor: Ki-Bum Lee, Rutgers University


Title: miRNA-regulated Differentiation-dependent Self-delecting Cassette

Patent Number: 8,697,851

Filed: Dec. 3, 2012

Lead Inventor: David Frendewey, Regeneron Pharmaceuticals


Title: microRNA and Methods for Inhibiting the Same

Patent Number: 8,697,859

Filed: Jan. 18, 2013

Lead Inventor: Markus Stoffel, Rockefeller University


Title: Temporal Regulation of Gene Expression by microRNAs

Patent Number: 8,697,949

Filed: June 26, 2008

Lead Inventor: Edwards Allen, Monsanto

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.